Publications en collaboration avec des chercheurs de University of Turku (13)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  2. Rehabilitation and outcomes after complicated vs uncomplicated mild TBI: results from the CENTER-TBI study

    BMC Health Services Research, Vol. 22, Núm. 1

  3. Serum metabolome associated with severity of acute traumatic brain injury

    Nature Communications, Vol. 13, Núm. 1

  4. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. DNA methylation signatures of aggression and closely related constructs: A meta-analysis of epigenome-wide studies across the lifespan

    Molecular Psychiatry, Vol. 26, Núm. 6, pp. 2148-2162

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Predictors of Access to Rehabilitation in the Year Following Traumatic Brain Injury: A European Prospective and Multicenter Study

    Neurorehabilitation and Neural Repair, Vol. 34, Núm. 9, pp. 814-830

2017

  1. Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance

    Cell Metabolism, Vol. 26, Núm. 1, pp. 212-229.e12

2007

  1. Corrigendum to "Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans" [J. Neuroimmunol. 179 (2006) 108-116] (DOI:10.1016/j.jneuroim.2006.06.003)

    Journal of Neuroimmunology

  2. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: A meta-analysis

    Tissue Antigens, Vol. 70, Núm. 2, pp. 110-127

  3. The TRIGR trial: Testing the potential link between weaning diet and type 1 diabetes

    Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Vol. 7, Núm. 3, pp. 251-263